Loading clinical trials...
Loading clinical trials...
Five to 10% of familial mediterranean patients are considered colchicine-resistant (i.e. patients with a persistent inflammatory syndrome, despite taking the maximum tolerated dose of colchicine daily...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
NCT00001373 · Familial Mediterranean Fever (FMF), Autoinflammation, and more
NCT06838143 · Hereditary Periodic Fever Syndromes, Cryopyrin-associated Periodic Syndromes (CAPS), and more
NCT07130305 · Familial Mediterranean Fever
NCT04478409 · Familial Mediterranean Fever, MEFV Gene Mutation
NCT07212764 · Familial Mediterranean Fever (FMF ), Infection, and more
Service de Médecine Interne. Hôpital Tenon, 4 Rue de la Chine
Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions